The challenge of approving add-on therapies for patients with metastatic cancer

Molecular medicine in lung cancer

Biomarker research in breast cancer

New biomarkers for response to immunotherapy

Combining immune-based therapies with TKIs in melanomas

Current and future immune approaches in precision medicine

Precision medicine enabled histology agnostic development of immunotherapeutics

DNA damage response inhibition

Big data, scientific wellness and transforming healthcare

Bayesian adaptive trial designs for precision medicine

Redesigning clinical trials in the era of precision medicine

Genomic-driven clinical studies in breast cancer